Synthesis, crystal structure and antiproliferative evaluation of some new substituted benzothiazoles and styrylbenzothiazoles

The multistep synthesis of a series of new substituted-benzothiazoles as hydrochloride or quaternary salts is described. 6-Amidino substituted 2-aminobenzothiazoles ( 5, 6), N-methyl-2-(4-cyanostyryl)benzothiazolium iodide ( 8), cyano-substituted-2-styrylbenzothiazoles ( 9-11) and amidino and bis-am...

Full description

Saved in:
Bibliographic Details
Published in:Farmaco (Società chimica italiana : 1989) Vol. 59; no. 4; pp. 297 - 305
Main Authors: Ćaleta, I., Grdiša, M., Mrvoš-Sermek, D., Cetina, M., Tralić-Kulenović, V., Pavelić, K., Karminski-Zamola, G.
Format: Journal Article
Language:English
Published: France Elsevier SAS 01-04-2004
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The multistep synthesis of a series of new substituted-benzothiazoles as hydrochloride or quaternary salts is described. 6-Amidino substituted 2-aminobenzothiazoles ( 5, 6), N-methyl-2-(4-cyanostyryl)benzothiazolium iodide ( 8), cyano-substituted-2-styrylbenzothiazoles ( 9-11) and amidino and bis-amidino-substituted 2-styrylbenzothiazoles ( 12-17) were prepared. The crystal structure of amidino derivative ( 6) was determined by single crystal X-ray analysis. All new prepared compounds were tested on the cytostatic activities against malignant cell lines: (SW620, colon carcinoma; Hep2, laryngeal carcinoma; HBL, melanoma; HeLa, cervical carcinoma and WI38, human normal fibroblasts). The compounds exerted a different inhibitory effect, depended on concentration and type of the cells. The best inhibitory effect was achieved with compounds ( 12-15), with slight differences among them. All of them inhibited the growth of examined tumor cell lines and also normal fibroblasts. Other examined compounds exhibited a moderate inhibitory effect, depending on type of the cells. Majority of them inhibited the growth of HeLa cells and WI38.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0014-827X
1879-0569
DOI:10.1016/j.farmac.2004.01.008